m+Medelevator.RU
← Поиск публикаций
Journal of cosmetic dermatology · 2025

Therapeutic Benefits of Topical Omega-3 Polyunsaturated Fatty Acids in Skin Diseases and Cosmetics: An Updated Systematic Review.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mateu-Arrom L, Mora I, Garrote L

Аннотация

BackgroundOral supplementation with omega-3 polyunsaturated fatty acids (ω-3 PUFAs) has shown beneficial effects in some dermatologic diseases (i.e., atopic dermatitis, acne, psoriasis, burns), but the actual effect of local application of ω-3 PUFAs for improving skin health is still under investigation.AimsThis paper systematically reviewed the current articles regarding the use of topical ω-3 PUFAs in the treatment of skin diseases to evaluate its efficacy and safety.MethodsThe review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) recommendations. Studies in which ω-3 PUFAs were administered as oral treatments, those with a reduced or unknown ω-3 PUFAs composition, and those using with skin fish grafts were excluded.ResultsIn skin models of psoriasis, wounds, dermatitis, and melanoma, topical ω-3 PUFAs showed an overall beneficial effect associated with the anti-inflammatory properties of these compounds. Furthermore, none of the studies reported cases of skin irritation, cytotoxicity, or any adverse events.ConclusionsThe increasing number of studies conducted on topical treatments with ω-3 PUFAs and the existing evidence suggest that ω-3 PUFAs could be a promising option as an adjuvant or complementary treatment in managing several dermatological conditions. However, there is still a lack of consensus about the optimal dosage, molecules, or delivery methods of ω-3 PUFAs; consequently, more clinical studies are needed.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты